Georgia Bio Sign-on to State Medical Technology Alliance HHS & CMS Letter

Georiga Bio sign-on to the State Medical Technology Alliance (SMTA) letter to U.S. Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid. Please see the language below.


The Honorable Alex M. Azar II
Secretary
U.S. Department of Health and Human Services
200 Independence Avenue, S.W.
Washington, D.C. 20201

The Honorable Seema Verma
Administrator
Centers for Medicare & Medicaid Services
7500 Security Boulevard
Baltimore, MD 21244


Dear Secretary Azar and Administrator Verma:

As members of the State Medical Technology Alliance (SMTA), we are state and regional life sciences associations representing biotechnology, medical device companies, universities, research institutions, and venture capital firms across the country, all dedicated to developing and delivering life-enhancing and life-saving products, we write to express our strong support for your leadership in the U.S. Department of Health and Human Services’ (HHS) efforts to provide coverage for transformative medical devices that are approved as breakthrough devices by the FDA.

The COVID-19 pandemic highlighted the need for our nation’s health care system to better align care for patients.  We commend HHS for taking swift action to create appropriate waivers and incentives across different health care stakeholders to better address this devastating disease.  Providing patients with access to breakthrough devices would further this push to align care for patients by promoting innovation and providing patients with the latest in life-changing medical technology.

The medical technology industry is an important and thriving sector in the U.S. economy, creating jobs in all 50 states and representing a sizable portion of the nation’s Gross Domestic Product.  The industry is responsible for about 1.9 million jobs in the U.S. and an economic output of approximately $381 billion annually.

Access to state-of-the art medical technology and diagnostics can help to improve care and patient outcomes, and CMS has acknowledged the value of breakthrough products by including a Breakthrough Product Pathway for new technology add-on payments (NTAP) in the Final Rule on the FY 2020 Inpatient Prospective Payment System. 

We commend HHS and CMS for these efforts and urge you to take the next step by providing coverage for all medical devices that are approved and cleared as FDA-designated breakthrough in all settings.  Providing this needed certainty will help ensure the next round of truly life-changing innovation can get to the patients who need them as quickly as possible.

As members of the SMTA, we look forward to working with the Administration to finalize this critical effort.



Sincerely,


Arizona BioIndustry Association (AZBio)

Biocom: Life Science Association of California

BioFlorida

BioForward Wisconsin

BioOhio

Bioscience Association of West Virginia (BioWV)

BioUtah

California Life Sciences Association (CLSA)

Colorado BioScience Association (CBSA)

Florida Medical Manufacturers Consortium (FMMC)

Georgia Bio

Healthcare Institute of New Jersey (HINJ)   

Illinois Biotechnology Innovation Organization (iBIO)

Indiana Health Industry Forum (IHIF)

Indiana Medical Device Manufacturers Council (IMDMC)

Iowa Biotechnology Association (IowaBio)

Kentucky Life Sciences Council

Life Sciences Pennsylvania

Life Science Tennessee

Life Science Washington

Massachusetts Medical Device Industry Council (MassMEDIC)

Medical Alley Association

MedTech Association New York

Michigan Biosciences Industry Association (MichBio)

Mississippi Biotechnology Association

Missouri Biotechnology Association (MOBIO)

NCBIO

SCBIO

Southeast Life Sciences

Texas Healthcare & Bioscience Institute (THBI)

Georgia Life Sciences Connects 23 Educators with Industry and Research at Savannah Regional Teacher Training Workshop

October 22, 2026
Georgia Life Sciences connected 23 educators with hands-on STEM learning and industry experts at its Savannah workshop to strengthen the workforce pipeline.

From Classroom to Industry: Forsyth County Teachers Explore Careers at Bend Bioscience

October 22, 2026
Georgia Life Sciences Institute connects 23 chemistry teachers with industry professionals to bring real-world career opportunities into the classroom. The Georgia Life Sciences Institute (GLSI) recently organized an industry visit for 23 Forsyth County chemistry teachers to Bend Bioscience in Gainesville, Georgia, offering educators a firsthand look at the careers, skills, and opportunities available within the state's growing life sciences sector. During the visit, teachers engaged directly with Bend Bioscience employees, toured the facility, and explored how concepts taught in chemistry classrooms translate into real-world applications. Conversations focused on workforce needs, career pathways, and the combination of technical and professional skills that help employees succeed in the life sciences industry. A particular area of interest was Quality Assurance and Quality Control (QA/QC), functions essential to maintaining the quality, safety, and consistency of life sciences products. These discussions helped educators better understand the range of careers available to students, including opportunities beyond traditional research and laboratory roles. The experience also demonstrated the impact of connecting educators directly with industry. Several participating teachers shared that the visit inspired them to discuss life sciences career opportunities with their own children, illustrating how greater career awareness can extend beyond the classroom. Both the educators and Bend Bioscience team expressed interest in continued engagement, reinforcing the value of building stronger connections between Georgia's schools and life sciences employers. Connecting Education and Industry Through initiatives like this visit, GLSI works to bridge the gap between education and industry by giving teachers direct exposure to the companies, technologies, and careers shaping Georgia's life sciences ecosystem. By equipping educators with firsthand industry knowledge, GLSI helps bring greater career awareness and real-world relevance into classrooms across the state, introducing students to pathways they may not have previously considered. Georgia Life Sciences Institute extends its appreciation to Bend Bioscience for welcoming Forsyth County educators and investing time in the teachers who help prepare Georgia's future workforce. Together, these partnerships are helping build awareness of the diverse opportunities available in Georgia's life sciences industry and strengthen the state's future talent pipeline.

Maximize Your JPM 2027 Week: Opportunities for GLS Members

October 20, 2026
J.P. Morgan Healthcare Week is one of the most business-forward weeks of the year for the life sciences industry—a time when companies, investors, strategic partners, and industry leaders come together to build relationships, explore investment opportunities, and advance innovation. GLS is helping our community make the most of the week with opportunities to connect, partner, and engage with the broader life sciences investment community. Here are a few events and member benefits to add to your calendar. State Bio Friends Kickoff 2027 📅 January 10 | 4:00–7:00 PM 📍 The Marker San Francisco 🎟️ To request a registration code, contact Stacey Bowlin at sbowlin@galifesciences.org . RESI JPM 2027 GLS is proud to partner with Life Science Nation to offer our community $300 off registration for RESI JPM 2027 . RESI JPM connects early-stage life sciences companies with investors, strategic partners, and industry leaders through networking, partnering, and programming focused on advancing innovation and investment. 📍 In person: January 11–12 | San Francisco Marriott Marquis 📅 Virtual partnering: January 13, 18, and 19 🎟️ Please use code GABIO to r eceive $300 off registration Biotech Showcase GLS is pleased to partner with Biotech Showcase to help connect our community with this important industry gathering. Taking place January 11-13, Biotech Showcase is a premier investor conference for private and emerging publicly traded biotech companies, bringing together innovators and investors to explore partnerships and financing opportunities. 📅 January 11–13 📍Hilton San Francisco Union Square 🎟️ Please use cod e supGALS2027 to receive $200 off registration Fierce JPM Week 📅 January 12–13 📍 Hyatt Regency San Francisco 🎟️ Secure your pass We encourage our members and partners to take advantage of these opportunities and represent Georgia’s growing life sciences community on the national stage. We look forward to connecting with you in San Francisco!
MORE POSTS